Eric Lefkofsky Seeks to Revolutionize Cancer Treatment with Tempus

Approximately 40% of American adults will face having cancer according to statistics. This terrible condition has been on the rise and by 2024, it could reach nearly 20 million American adults. Fortunately, medicine is advancing and Tempus and other companies are investing in the treatment of cancer and making survival more attainable with data-enabled precision medicine. Tempus is led by Eric Lefkofsky who is one of the co-founders.

Electronic health records (EHRs) have come into mainstream usage and should help further the use of technology in medicine. Contrary to expectations, huge amounts of data are collected but still not made available to health professionals in a standard way, which could save time and lives in the treatment of cancer and other diseases.

Tempus has the goal of transforming the way cancer care is done. The platform Tempus is developing should be able to analyze the clinical and molecular data of a patient. Tempus is able to develop the software for this, but obtaining medical data was an initial obstacle. In cancer treatment, much data that is collected by physicians is not structured into data, but with Tempus’ optical recognition capabilities and natural language processing software, the data collected in the progression of patients could be put to use to improve their treatment of cancer.

Tempus is also working on molecular data that would include genomic information from the human genome sequencing project. The cost of genome sequencing of an individual is affordable but still not very cheap. Tempus expects to be able to help the price of human genome sequencing become even more affordable. Tempus has the objective of combining molecular information, clinical data from patients and genome sequencing to make fighting diseases not only a reactive and possibly avoiding repetitive unnecessary testing in fighting against cancer as well as other diseases and learn more about Eric Lefkofsky.

Eric Lefkofsky is from Southfield, Michigan. He holds a Juris Doctor degree from the University of Michigan. Lefkofsky is considered a power player in the IT and dot-com areas and more information click here.

Currently, Lefkofsky is on the board of directors at Lurie’s Children’s Memorial Hospital, as well as the Art Institute of Chicago. In the same area of art, Lefkofsky is also a board trustee and chairman of Chicago’s Steppenwolf Theatre Company. Eric Lefkofsky has taught at DePaul University’s Kellstadt Graduate School of Business and also at Northwestern University’s Kellogg School of Management. Lefkofsky now teaches at the University of Chicago’s Booth School of Business and Eric Lefkofsky’s lacrosse camp.

Leave a Reply

Your email address will not be published. Required fields are marked *